IFNG and lung carcinoma: Our previous data showed that A‐CpG ODN inhibits tumor growth in a mouse model via poly‐G motif‐mediated T cell activation.20 Our present data indicate the possibility of enhancement of antitumor immune responses to A‐CpG ODN via the IFN‐γ pathway in human lung cancer.